Johnson and Johnson News
News on Johnson and Johnson (Ticker: JNJ) continually updated from thousands of sources around the net.
2 hrs ago | ComputerWorld
IBM continues to make the case for the nascent field of cognitive computing, showing off some Watson prototypes Thursday that could help speed scientific discovery in the medical field, by scanning large volumes of literature and data far more quickly then humans can, and suggesting possible leads.
3 hrs ago | TheStreet.com
Your browser is not supported. Please upgrade to one of the following browsers: Google Chrome Mozilla Firefox Apple Safari Microsoft Internet Explorer 8+ You may proceed to the site by clicking here , however some pages might not work correctly.
7 hrs ago | Reuters
Johnson & Johnson is recalling some lots of its implant used to correct defects of the jaw following more than a dozen cases of injury.
7 hrs ago | CBC News
Johnson & Johnson is recalling some lots of its implant used to correct defects of the jaw, following more than a dozen cases of injury.
7 hrs ago | The Motley Fool
Europe had already shown its willingness to support the use of daclatasvir, which will be sold under the brand name Daklinza, when it gave the OK for its compassionate use program last fall.
11 hrs ago | Heraldseries.co.uk
The county's economy grew by 3.5 per cent last year, compared with the national rate of 3.2 per cent, making it the second-best-performing area in the south east.
New Brunswick-based Johnson & Johnson wants to hire workers. What it doesn't want is a flood of applicants taking a flier in a tough job market, a common occurrence in the aftermath of the recession.
International Business Machines Corp on Wednesday launched a computer system that can quickly identify patterns in massive amounts of data, an ability that IBM said should hasten breakthroughs in science and medical research.
I recently had a prospective client come to me with an interesting case. He and his wife have $800,000 saved, half of which is in an IRA.
ViaCyte, Inc., a privately held regenerative medicine company announced that it has entered into a Rights Agreement with Janssen Research & Development LLC , one of the Janssen Pharmaceutical Companies of Johnson & Johnson.
Vivus has acquired a group of patents covering one of the main ingredients behind its weight loss drug Qsymia from Janssen Pharmaceuticals.
I have been recommending Gilead for the past 3 years, and for the past 2 years my price target has been $140.
Big pharma and one relatively small company are teaming up to develop a master test that will help doctors pick a combination of drugs tailored to the individual patient's condition.
Johnson & Johnson is appreciating a decent time in 2014, liking 10% and beating the more extensive market so far.
San Diego's ViaCyte has received $20 million from a drug company to advance its stem cell-based therapy for Type 1 diabetes into human clinical trials.
Updated: Thu Aug 28, 2014 04:08 pm
Copyright © 2014 Topix LLC